• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4616374)   Today's Articles (658)   Subscriber (49394)
For: Lilleng H, Abeler K, Johnsen SH, Stensland E, Løseth S, Lindal S, Wilsgaard T, Bekkelund SI. Clinical impact of persistent hyperCKemia in a Norwegian general population: A case-control study. Neuromuscul Disord 2013;23:29-35. [DOI: 10.1016/j.nmd.2012.07.008] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2012] [Revised: 07/06/2012] [Accepted: 07/18/2012] [Indexed: 10/27/2022]
Number Cited by Other Article(s)
1
Bekkelund SI, Abeler K, Lilleng H, Løseth S. A case control study of the relationship between persistent serum creatine kinase elevation and polyneuropathy. Sci Rep 2024;14:13816. [PMID: 38879579 PMCID: PMC11180140 DOI: 10.1038/s41598-024-64555-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2024] [Accepted: 06/11/2024] [Indexed: 06/19/2024]  Open
2
Kyriakides T, Angelini C, Vilchez J, Hilton‐Jones D. European Federation of the Neurological Societies guidelines on the diagnostic approach to paucisymptomatic or asymptomatic hyperCKemia. Muscle Nerve 2019;61:E14-E15. [DOI: 10.1002/mus.26777] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2019] [Revised: 11/13/2019] [Accepted: 11/24/2019] [Indexed: 12/15/2022]
3
Venance SL. Approach to the Patient With HyperCKemia. Continuum (Minneap Minn) 2018;22:1803-1814. [PMID: 27922494 DOI: 10.1212/01.con.0000511069.68640.39] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
4
Haan YC, Oudman I, Diemer FS, Karamat FA, van Valkengoed IG, van Montfrans GA, Brewster LM. Creatine kinase as a marker of obesity in a multi-ethnic population. Mol Cell Endocrinol 2017;442:24-31. [PMID: 27894867 DOI: 10.1016/j.mce.2016.11.022] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/15/2016] [Revised: 11/10/2016] [Accepted: 11/23/2016] [Indexed: 11/16/2022]
5
Johnsen SH, Lilleng H, Bekkelund SI. Reply: creatine kinase, overweight, and hypertension--the issue is more complex than we thought. J Clin Hypertens (Greenwich) 2015;17:323. [PMID: 25625689 DOI: 10.1111/jch.12488] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
6
Johnsen SH, Lilleng H, Bekkelund SI. Creatine Kinase as Predictor of Blood Pressure and Hypertension. Is It All About Body Mass Index? A Follow-Up Study of 250 Patients. J Clin Hypertens (Greenwich) 2014;16:820-6. [DOI: 10.1111/jch.12422] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2014] [Revised: 08/20/2014] [Accepted: 08/22/2014] [Indexed: 11/30/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA